# Clinical trials recruiting in Armenia: 30 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 30 trials recruiting or not yet recruiting with a site in Armenia, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Armenia: 30 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/armenia

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 30
- Recruiting or not yet: 30
- Read on: November 19, 2026

## Trials

The 25 newest of 30, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 8, 2026 | NCT07632014 | CAYA Cancer Prospective Cohort Study | Resonance, Inc. | Observational | Recruiting | Cancer, Pediatric Cancer, Lymphoblastic Lymphoma (LBL), Acute Lymphoblastic Leukemia (ALL) | 6,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07632014) |
| May 19, 2026 | NCT07595016 | Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 in Pregnancy and Pre-Eclampsia | Withings | Not applicable | Recruiting | Hypertension, Pre-eclampsia | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07595016) |
| May 13, 2026 | NCT07583446 | Randomized Evaluation of Istaroxime for Stabilization in Acute Heart Failure-Cardiogenic Shock | Seismic Pharmaceuticals Operations LLC | Phase 2/3 | Recruiting | Cardiogenic Shock | 600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07583446) |
| January 8, 2026 | NCT07325097 | PVEK Corneal Implant For Treatment of Corneal Edema | Sponsor not shown (see the record) | Phase 1 | Recruiting | Corneal Edema, Fuchs' Endothelial Dystrophy, Pseudophakic Bullous Keratopathy, Corneal Endothelial Dysfunction | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07325097) |
| November 24, 2025 | NCT07246213 | CAYA Cancer Retrospective Cohort Study | Resonance, Inc. | Observational | Recruiting | Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Young Adult Cancer, Adolescent Cancer, Childhood Cancers, Acute... | 18,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07246213) |
| September 5, 2025 | NCT07156916 | A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin... | Berlin-Chemie AG Menarini Group | Phase 1 | Recruiting | Healthy Volunteer Male Subjects | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07156916) |
| June 3, 2025 | NCT07001852 | EnDOvascular Therapy for Late WiNdow IschEmic Stroke Patients Selected bY AutoMatic Plain ComputErized Tomography | Sponsor not shown (see the record) | Not applicable | Recruiting | Stroke Acute | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07001852) |
| March 7, 2025 | NCT06864351 | Prospective Evaluation of OptiThyDose | University Children's Hospital Basel | Not applicable | Recruiting | Thyroid Diseases, Congenital Hypothyroidism, Graves Disease | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06864351) |
| February 18, 2025 | NCT06832722 | A Phase 1b/2a Trial to Evaluate Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care. | 4TEEN4 Pharmaceuticals GmbH | Phase 1/2 | Recruiting | Shock, Cardiogenic | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06832722) |
| December 27, 2024 | NCT06748924 | Chronic Coronary Syndrome Snapshot Study | European Society of Cardiology | Observational | Recruiting | Chronic Coronary Syndrome | 4,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06748924) |
| December 4, 2024 | NCT06715579 | Cardiac Angiosarcoma International Registry | Immune Oncology Research Institute | Observational | Recruiting | Cardiac Angiosarcoma | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06715579) |
| October 26, 2024 | NCT06659549 | A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD | Galimedix Therapeutics Inc | Phase 2 | Recruiting | Geographic Atrophy of the Macula | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06659549) |
| August 1, 2024 | NCT06533813 | Clinical Epidemiology in Contemporary Patients With Myelofibrosis. | FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | Observational | Recruiting | Myelofibrosis | 617 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06533813) |
| June 20, 2024 | NCT06466785 | A Phase 3 Study of Efepoetin Alfa for Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis | Genexine, Inc. | Phase 3 | Recruiting | Anemia of Chronic Kidney Disease | 429 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06466785) |
| May 7, 2024 | NCT06402188 | ColoSeal™ ICD System Safety and Feasibility Studies | Averto Medical, Inc. | Not applicable | Recruiting | Colorectal Cancer | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06402188) |
| May 1, 2024 | NCT06395129 | Low Dead-space Injecting Equipment Distribution Program for People Who Inject Drugs in Low- and Middle-income Countries | Sponsor not shown (see the record) | Observational | Recruiting | Drug Use, Hepatitis, Hiv | 2,400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06395129) |
| April 12, 2024 | NCT06361537 | Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and... | Octapharma | Phase 3 | Recruiting | Acute Hereditary Angio Edema | 124 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06361537) |
| December 6, 2023 | NCT06159504 | Simplifying Hepatitis C Pathways for People Who Inject Drugs in Armenia, Georgia, and Tanzania | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Hepatitis C, RDT | 3,040 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06159504) |
| July 7, 2023 | NCT05935189 | Establishment of a Tissue Registry for Hepatocellular Carcinoma Specimens | Nikomed Medical Center | Observational | Recruiting | Hepatocellular Carcinoma | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05935189) |
| June 15, 2023 | NCT05904301 | Armenian NAtionwide REGistry of Systemic Autoimmune and Autoinflammatory Diseases | Santé Arménie French-Armenian Research Center | Observational | Recruiting | Behcet Disease, Antineutrophil Cytoplasmic Antibody (ANCA) Positive Vasculitis, Takayasu Arteritis, Giant Cell... | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05904301) |
| June 7, 2023 | NCT05891821 | Assessment of the Safety and Efficacy of Balstilimab for the Treatment of Relapsed/Refractory Lymphomas (IMMONC0001) | Immune Oncology Research Institute | Phase 2 | Recruiting | Lymphoma | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05891821) |
| February 3, 2023 | NCT05711992 | Rare Embryonal Tumors of the Central Nervous System: International Registry | Immune Oncology Research Institute | Observational | Recruiting | Embryonal Tumor | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05711992) |
| January 26, 2023 | NCT05700149 | Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma | International Extranodal Lymphoma Study Group (IELSG) | Observational | Recruiting | Nodal Marginal Zone Lymphoma | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05700149) |
| October 20, 2022 | NCT05588323 | Safety and Pharmacokinetics Study of Naldemedine in Paediatric Participants Receiving Opioids | Shionogi | Phase 1/2 | Recruiting | Opioid-Induced Constipation (OIC) | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05588323) |
| June 24, 2022 | NCT05430971 | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry | Immune Oncology Research Institute | Observational | Recruiting | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05430971) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Yeolyan Center for Cancer and Blood Disorders | Yerevan | 2 |
| Erebouni Medical Center | Yerevan | 2 |
| Erebuni Medical Center | Yerevan | 2 |
| National Center of Oncology Named After V.A. Fanarjyan | Yerevan | 2 |
| Yeolyan Hematology and Oncology Centre | Yerevan | 1 |
| CARDIOMED Family Health Center, LLC of the Ministry of Health of the Republic of Armenia | Yerevan | 1 |
| Institute of Fine Organic Chemistry of the National Academy of Science | Yerevan | 1 |
| Scientific Center of Drug and Medical Technologies Expertise | Yerevan | 1 |
| Nikomed Medical Center | Yerevan | 1 |
| National Institute for Infectious Diseases | Yerevan | 1 |
| "ARABKIR" Joint Medical Center & Institute of Child and Adolescent Health | Yerevan | 1 |
| "BEST LIFE" Medical Center Armenian-Japanese Joint Venture LLC | Yerevan | 1 |
| 'Astghik'' Medical Center | Yerevan | 1 |
| Arabkir Medical Cente & Institute of child and adolescent Health LLC | Yerevan | 1 |
| Yerevan medical scientific center | Yerevan | 1 |
| Erebouni Mwdical Center | Yerevan | 1 |
| Yeolyan Hematology. , and Oncology Center | Yerevan | 1 |
| National Center of Oncology after V.A. Fanarjian | Yerevan | 1 |
| Yeolyan Hematology and Oncology Center | Yerevan | 1 |
| Ophthalmological Center After S.V. Malayan | Yerevan | 1 |
| Center of Medical Genetics and Primary Health Care LLC | Yerevan | 1 |
| Institute of Surgery Mikayelyan CJSC | Yerevan | 1 |
| Nairi Medical Center, Rheumatology Department | Yerevan | 1 |
| Heratsi Hospital Complex n°1, Rheumatology Department | Yerevan | 1 |
| Heratsi Hospital Complex №1, Allergology Department | Yerevan | 1 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 5 |
| Phase 1/2 | 2 |
| Phase 2 | 3 |
| Phase 2/3 | 1 |
| Phase 3 | 3 |
| Not applicable | 4 |
| Observational | 11 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Neoplasms | 2 |
| Shock, Cardiogenic | 2 |
| Angioedema | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Myelodysplastic Syndromes | 2 |
| Lymphoma | 1 |
| Lymphoma, B-Cell, Marginal Zone | 1 |
| Neoplasms, Germ Cell and Embryonal | 1 |
| Carcinoma, Hepatocellular | 1 |
| Hepatitis C | 1 |
| Thyroid Diseases | 1 |
| Congenital Hypothyroidism | 1 |
| Graves Disease | 1 |
| Opioid-Induced Constipation | 1 |
| Primary Myelofibrosis | 1 |
| Colorectal Neoplasms | 1 |
| Hemangiosarcoma | 1 |
| Geographic Atrophy | 1 |
| Macular Degeneration | 1 |
| Plaque, Amyloid | 1 |
| Hepatitis | 1 |
| Acquired Immunodeficiency Syndrome | 1 |
| Harm Reduction | 1 |
| Familial Mediterranean Fever | 1 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Immune Oncology Research Institute | 4 |
| [Octapharma](https://specstream.ai/data/clinical-trials/company/octapharma) | 2 |
| Resonance, Inc. | 2 |
| [Taiho Oncology, Inc.](https://specstream.ai/data/clinical-trials/company/taiho-oncology-inc) | 2 |
| International Extranodal Lymphoma Study Group (IELSG) | 1 |
| EuroPharma, Inc. | 1 |
| Nikomed Medical Center | 1 |
| [Genexine, Inc.](https://specstream.ai/data/clinical-trials/company/genexine-inc) | 1 |
| University Children's Hospital Basel | 1 |
| 4TEEN4 Pharmaceuticals GmbH | 1 |
| [Shionogi](https://specstream.ai/data/clinical-trials/company/shionogi) | 1 |
| FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS | 1 |
| Averto Medical, Inc. | 1 |
| Galimedix Therapeutics Inc | 1 |
| R-Pharm International, LLC | 1 |
| Seismic Pharmaceuticals Operations LLC | 1 |
| Santé Arménie French-Armenian Research Center | 1 |
| European Society of Cardiology | 1 |
| Berlin-Chemie AG Menarini Group | 1 |
| [Withings](https://specstream.ai/data/clinical-trials/company/withings) | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Freight and cargo companies in the United States](https://specstream.ai/data/businesses/freight-and-cargo-companies/united-states)
- [Fast food restaurants in the United States](https://specstream.ai/data/businesses/fast-food-restaurants/united-states)
- [Endocrinology practices in the United States](https://specstream.ai/data/businesses/endocrinology-practices/united-states)
- [Drywall contractors in the United States](https://specstream.ai/data/businesses/drywall-contractors/united-states)
- [Damage restoration companies in the United States](https://specstream.ai/data/businesses/damage-restoration-companies/united-states)
- [Commercial real estate firms in the United States](https://specstream.ai/data/businesses/commercial-real-estate-firms/united-states)
